Etanercept for Treatment of Hidradenitis

Etanercept for Treatment of Hidradenitis


Etanercept for Treatment of Hidradenitis

Acronym: null
Other IDs: 802687|0305
NCT Number: NCT00107991
Sponsor Collaborators: University of Pennsylvania
Funding: Other


HIDRADENITIS SUPPURATIVA CLINICAL TRIAL STATUS

Recruiting Status: Completed
Recruiting Genders: Both
Recruiting Age Groups: Adult|Senior
Interventions: Drug: etanercept
Phases: Phase 2


CLINICAL STUDY DETAILS & RESULTS

STUDY TYPES: Interventional
STUDY DESIGNS: Allocation: Non-Randomized|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Primary Purpose: Treatment|Masking: Open Label
Results First Received: January 4, 2011
Study Result (if available): Has Results
Primary Completion Date: August 2008
Outcome Measures: Physician’s Global Assessment Score – Response Rate (Percentage)|Number of Lesions (Response Rate – Percentage)|Patient Global Assessment|Patient’s Pain Score|Dermatology Life Quality Index Score (DLQI)


CLINICAL STUDIES DATES & MILESTONES

First Received: April 11, 2005
Start Date: April 2005
Completion Date: November 2008
Last Updated: January 4, 2011
last Verified: January 2011


Source: https://ClinicalTrials.gov/show/NCT00107991


Public Domain Source: ClinicalTrials.gov query for “Hidradenitis suppurativa” clinical studies (last updated January 2016).


Tags:
0 Comments

Leave a reply

HSAWARENESS.ORG | Fighting for Hidradenitis suppurativa (HS), a.k.a Acne Inversa Patient and Doctor Awareness ©2017 hidradenitissuppurativaawareness.org  All Rights Reserved. Your use of this website constitutes explicit agreement to our Terms of Use and Privacy Policies. This website does not provide medical advice, diagnosis or treatment.

Log in with your credentials

Forgot your details?